当前位置: 首页 >> 检索结果
7921. Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial.
作者: Deepak L Bhatt.;John W Eikelboom.;Stuart J Connolly.;P Gabriel Steg.;Sonia S Anand.;Subodh Verma.;Kelley R H Branch.;Jeffrey Probstfield.;Jackie Bosch.;Olga Shestakovska.;Michael Szarek.;Aldo Pietro Maggioni.;Petr Widimský.;Alvaro Avezum.;Rafael Diaz.;Basil S Lewis.;Scott D Berkowitz.;Keith A A Fox.;Lars Ryden.;Salim Yusuf.; .
来源: Circulation. 2020年141卷23期1841-1854页
Patients with established coronary artery disease or peripheral artery disease often have diabetes mellitus. These patients are at high risk of future vascular events.
7922. Cardiovascular Mortality and Exposure to Heat in an Inherently Hot Region: Implications for Climate Change.
作者: Barrak Alahmad.;Haitham Khraishah.;Ahmed F Shakarchi.;Mazen Albaghdadi.;Sanjay Rajagopalan.;Petros Koutrakis.;Farouc A Jaffer.
来源: Circulation. 2020年141卷15期1271-1273页 7923. CSC Expert Consensus on Principles of Clinical Management of Patients With Severe Emergent Cardiovascular Diseases During the COVID-19 Epidemic.
作者: Yaling Han.;Hesong Zeng.;Hong Jiang.;Yuejin Yang.;Zuyi Yuan.;Xiang Cheng.;Zhicheng Jing.;Bin Liu.;Jiyan Chen.;Shaoping Nie.;Jianhua Zhu.;Fei Li.;Changsheng Ma.
来源: Circulation. 2020年141卷20期e810-e816页
In response to the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, the Chinese Society of Cardiology (CSC) issued this consensus statement after consulting with 125 medical experts in the fields of cardiovascular disease and infectious disease. The over-arching principles laid out here are the following: 1) Consider the prevention and control of COVID-19 transmission as the highest priority, including self-protection of medical staff; 2) Patient risk assessment of both infection and cardiovascular issues. Where appropriate, preferential use of conservative medical therapeutic approaches to minimize disease spread; 3) At all times, medical practices and interventional procedures should be conducted in accordance with the directives of the infection control department of local hospitals and local health commissions.
7924. Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry.
作者: Sabato Sorrentino.;Samantha Sartori.;Usman Baber.;Bimmer E Claessen.;Gennaro Giustino.;Jaya Chandrasekhar.;Rishi Chandiramani.;David J Cohen.;Timothy D Henry.;Paul Guedeney.;Cono Ariti.;George Dangas.;C Michael Gibson.;Mitchell W Krucoff.;David J Moliterno.;Antonio Colombo.;Birgit Vogel.;Alaide Chieffo.;Annapoorna S Kini.;Bernhard Witzenbichler.;Giora Weisz.;Philippe Gabriel Steg.;Stuart Pocock.;Philip Urban.;Roxana Mehran.
来源: Circ Cardiovasc Interv. 2020年13卷4期e008226页
Whether the underlying risk of bleeding influences the associations between patterns of dual antiplatelet therapy (DAPT) cessation and adverse events after percutaneous coronary intervention is unknown.
7925. Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction: A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial.
作者: Axel Wester.;Rubina Attar.;Moman A Mohammad.;Nazim Isma.;Stefan James.;Elmir Omerovic.;David Erlinge.;Sasha Koul.
来源: Circ Cardiovasc Interv. 2020年13卷4期e008671页
Elderly patients with acute myocardial infarction undergoing percutaneous coronary intervention are at increased risk of both ischemic and bleeding complications. The optimal anticoagulation strategy in these patients is uncertain. Therefore, we compared bivalirudin to heparin monotherapy in a contemporary cohort of such patients.
7927. Heart Transplantation in Muscular Dystrophy Patients: Is it a Viable Option?
作者: Dennis Wells.;Raheel Rizwan.;John L Jefferies.;Roosevelt Bryant.;Thomas D Ryan.;Angela Lorts.;Clifford Chin.;Farhan Zafar.;David L Morales.
来源: Circ Heart Fail. 2020年13卷4期e005447页
Cardiomyopathy is a common complication among muscular dystrophy (MD) patients and often results in advanced heart failure and premature death. In spite of this, there is hesitancy to consider heart transplantation (HTx). This study describes the HTx outcomes in patients with MD in the United States.
7930. Thirty-Day Readmissions After Carotid Artery Stenting Versus Endarterectomy: Analysis of the 2013-2014 Nationwide Readmissions Database.
作者: Fabio V Lima.;Dhaval Kolte.;Kevin F Kennedy.;Lily J Wang.;J Dawn Abbott.;Peter A Soukas.;Herbert D Aronow.
来源: Circ Cardiovasc Interv. 2020年13卷4期e008508页
Contemporary, nationally representative 30-day readmissions data after carotid artery stenting (CAS) and carotid endarterectomy (CEA) are lacking.
7932. Appropriateness of Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.
作者: Taku Inohara.;Sreekanth Vemulapalli.;Shun Kohsaka.;Fumiaki Yashima.;Yusuke Watanabe.;Shinichi Shirai.;Norio Tada.;Motoharu Araki.;Toru Naganuma.;Futoshi Yamanaka.;Hiroshi Ueno.;Minoru Tabata.;Kazuki Mizutani.;Akihiro Higashimori.;Kensuke Takagi.;Masanori Yamamoto.;Hideyuki Shimizu.;Keiichi Fukuda.;Kentaro Hayashida.; .
来源: Circ Cardiovasc Qual Outcomes. 2020年13卷4期e006146页
Transcatheter aortic valve replacement (TAVR) is widely used; however, its appropriateness is unknown. We sought to investigate the appropriateness of TAVR.
7935. Murphy's Law or Domino Effect: Severe Aortic Annular Calcification in Transcatheter Aortic Valve Replacement.
作者: Richard Ro.;Gilbert H L Tang.;Sahil Khera.;Parasuram Krishnamoorthy.;Samin K Sharma.;Annapoorna Kini.;Stamatios Lerakis.
来源: Circ Cardiovasc Imaging. 2020年13卷4期e010162页 7940. Testing for Coronary Artery Disease in Older Patients With New-Onset Heart Failure: Findings From Get With The Guidelines-Heart Failure.
作者: Kyle D O'Connor.;Todd Brophy.;Gregg C Fonarow.;Ron Blankstein.;Rajesh V Swaminathan.;Haolin Xu.;Roland A Matsouaka.;Nancy M Albert.;Eric J Velazquez.;Clyde W Yancy.;Paul A Heidenreich.;Adrian F Hernandez.;Adam D DeVore.
来源: Circ Heart Fail. 2020年13卷4期e006963页
Current guidelines recommend evaluation for underlying heart disease and reversible conditions for patients with new-onset heart failure (HF). There are limited data on contemporary testing for coronary artery disease (CAD) in patients with new-onset HF.
|